Medovex Corp Stock Working Capital
| HCYTDelisted Stock | USD 2.21 0.00 0.00% |
Medovex Corp fundamentals help investors to digest information that contributes to Medovex Corp's financial success or failures. It also enables traders to predict the movement of Medovex OTC Stock. The fundamental analysis module provides a way to measure Medovex Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medovex Corp otc stock.
Medovex |
Medovex Corp OTC Stock Working Capital Analysis
Medovex Corp's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Medovex Corp Working Capital | 3.33 M |
Most of Medovex Corp's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medovex Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionAccording to the company's disclosures, Medovex Corp has a Working Capital of 3.33 M. This is 99.22% lower than that of the Healthcare sector and 99.38% lower than that of the Biotechnology industry. The working capital for all United States stocks is 99.77% higher than that of the company.
Medovex Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medovex Corp's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Medovex Corp could also be used in its relative valuation, which is a method of valuing Medovex Corp by comparing valuation metrics of similar companies.Medovex Corp is currently under evaluation in working capital category among its peers.
Medovex Fundamentals
| Return On Equity | -4.6 | |||
| Return On Asset | -3.48 | |||
| Operating Margin | (3.51) % | |||
| Current Valuation | 8.88 M | |||
| Shares Outstanding | 477.61 K | |||
| Shares Owned By Insiders | 25.51 % | |||
| Number Of Shares Shorted | 294 | |||
| Price To Earning | (1.53) X | |||
| Price To Book | 34.90 X | |||
| Price To Sales | 3.68 X | |||
| Revenue | 1.61 M | |||
| Gross Profit | 906.81 K | |||
| EBITDA | (4.61 M) | |||
| Net Income | (4.8 M) | |||
| Cash And Equivalents | 45.88 K | |||
| Cash Per Share | 0.16 X | |||
| Total Debt | 3.88 M | |||
| Debt To Equity | 2.61 % | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (17.98) X | |||
| Cash Flow From Operations | (4.81 M) | |||
| Short Ratio | 3.47 X | |||
| Earnings Per Share | (0.05) X | |||
| Target Price | 1.75 | |||
| Beta | 0.73 | |||
| Market Capitalization | 1.06 M | |||
| Total Asset | 321.4 K | |||
| Retained Earnings | (38.35 M) | |||
| Working Capital | 3.33 M | |||
| Current Asset | 4.18 M | |||
| Current Liabilities | 851.22 K | |||
| Net Asset | 321.4 K |
About Medovex Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medovex Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medovex Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medovex Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Medovex OTC Stock
If you are still planning to invest in Medovex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medovex Corp's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |